Literature DB >> 13716837

Serum albumin, pseudocholine-sterase, and transaminases in the assessment of liver function before and after venous shunt operations.

A H HUNT, H LEHMANN.   

Abstract

This paper records biochemical and follow-up observations on 153 patients with cirrhosis who have had a shunt operation. The experience confirms that no shunt operation should be undertaken on a patient whose serum albumin level is less than 3.2g.%. Low pseudocholinesterase levels are of help diagnostically but the main value of this test is in indicating whether or not liver function will deteriorate after a shunt operation in any given patient.

Entities:  

Keywords:  CHOLINESTERASE/blood; PORTACAVAL ANASTOMOSIS; SERUM ALBUMIN; TRANSAMINASES/blood

Mesh:

Substances:

Year:  1960        PMID: 13716837      PMCID: PMC1413234          DOI: 10.1136/gut.1.4.303

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  8 in total

1.  Results of treatment from porta-caval anastomosis, lieno-renal anastomosis and hepatic artery ligation.

Authors:  A HUNT
Journal:  Proc R Soc Med       Date:  1959-04

2.  The pseudocholinesterase variants. Esterase levels and dibucaine numbers in families selected through suxamethonium sensitive individuals.

Authors:  H HARRIS; M WHITTAKER; H LEHMANN; E SILK
Journal:  Acta Genet Stat Med       Date:  1960

3.  Some statistical data on atypical cholinesterase of human serum.

Authors:  W KALOW; D R GUNN
Journal:  Ann Hum Genet       Date:  1959-07       Impact factor: 1.670

4.  A method for the detection of atypical forms of human serum cholinesterase; determination of dibucaine numbers.

Authors:  W KALOW; K GENEST
Journal:  Can J Biochem Physiol       Date:  1957-06

5.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases.

Authors:  S REITMAN; S FRANKEL
Journal:  Am J Clin Pathol       Date:  1957-07       Impact factor: 2.493

6.  Routine methods for the estimation of serum transaminase.

Authors:  J KING
Journal:  J Med Lab Technol       Date:  1958-01

7.  Serum glutamic pyruvic transaminase SGP-T in hepatic disease: a preliminary report.

Authors:  J S LADUE; F WROBLEWSKI
Journal:  Ann Intern Med       Date:  1956-11       Impact factor: 25.391

8.  The inhibitory action of eserine upon choline-esterase in vivo.

Authors:  M S Jones; H Tod
Journal:  Biochem J       Date:  1935-09       Impact factor: 3.857

  8 in total
  5 in total

1.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1961-06-24

2.  Low serum pseudocholinesterase levels complicating treatment with phenelzine.

Authors:  P O Bodley; K Halwax; L Potts
Journal:  Br Med J       Date:  1969-08-30

3.  Separation of serum cholinesterase isozymes by an improved polyacrylamide gel electrophoresis and its application for the study of liver diseases (Part I).

Authors:  S Matsuzaki; K Iwamura; T Katsunuma; H Kamiguchi
Journal:  Gastroenterol Jpn       Date:  1980

4.  Abnormalities of serum cholinesterase isozyme in liver cirrhosis and hepatoma (Part II).

Authors:  S Matsuzaki; K Iwamura; M Itakura; T Katsunuma
Journal:  Gastroenterol Jpn       Date:  1980

5.  The evaluation of serum pseudocholinesterase as a liver function test.

Authors:  M G KHAN
Journal:  Ulster Med J       Date:  1962-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.